Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|November 15, 2000
Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerasesA Kruczynski, C Etiévant, D Perrin, et al.
Brain Research|March 21, 2018
NLX-112, a highly selective 5-HT1A receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT1A receptors, respectivelyA Newman-Tancredi, L Bardin, A Auclair, et al.
Neuroscience|October 29, 2002
Protective effects of the alpha 2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult ratT Debeir, M Marien, P Chopin, et al.
Biochemical Pharmacology|March 27, 1998
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloidA Kruczynski, J M Barret, C Etiévant, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloidA Kruczynski, F Colpaert, J P Tarayre, et al.
Experimental Neurology|November 9, 2004
In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegenerationThomas Debeir, M Marien, J Ferrario, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenograftsB T Hill, H H Fiebig, W R Waud, et al.
Journal of Neurochemistry|October 12, 2001
Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stressJ D Troadec, M Marien, F Darios, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 1, 2005
Conformational analysis and crystal structure of {[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4yl]methyl}[(5-methylpyridin-2-yl)methyl]amine, fumaric acid saltJ P Ribet, R Pena, J L Maurel, et al.
British Journal of Pharmacology|March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophreniaR Depoortère, L Bardin, A L Auclair, et al.
Pageof 3